Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Exagamglogene autotemcel (Casgevy) goedgekeurd voor sikkelcelziekte en transfusieafhankelijke bètathalassemie
feb 2024 | Benigne hematologie